Journal of Pain & Relief
Open Access

Carpal tunnel syndrome; Nocturnal splinting; Median nerve; Treatment; Conservative therapy; Symptoms; Hand function; Clinical studies

Introduction

Carpal Tunnel Syndrome (CTS) is one of the most prevalent entrapment neuropathies, predominantly affecting individuals involved in repetitive hand movements or those with underlying conditions such as diabetes or rheumatoid arthritis. The condition arises when the median nerve, which controls sensation and motor function in the hand, becomes compressed as it passes through the carpal tunnel at the wrist. Symptoms include pain, tingling, numbness, and weakness, particularly in the thumb, index, and middle fingers. The traditional treatment for CTS includes both non-surgical and surgical interventions. Nocturnal splinting, a conservative and non-invasive approach, is often recommended to reduce the nocturnal symptoms associated with CTS, such as hand numbness and discomfort that may interfere with sleep. This article aims to assess the role of nocturnal splinting in managing CTS, its effectiveness, and the various factors that influence its success [1,2].

Description

Nocturnal splinting involves wearing a wrist brace or splint while sleeping, with the goal of keeping the wrist in a neutral position. This position helps reduce pressure on the median nerve, alleviating the symptoms associated with CTS. The splint typically holds the wrist in a slightly extended position, preventing flexion and reducing the mechanical stress on the nerve. Various designs of splints exist, ranging from prefabricated models to custom-made ones, with materials that vary from rigid plastic to soft, flexible options. The duration of treatment and compliance with wearing the splint also play crucial roles in its effectiveness. Some studies suggest that a few weeks of nightly use may provide sufficient relief from symptoms, while others recommend longer treatment periods for sustained benefits [3,4].

The primary mechanism by which nocturnal splinting alleviates CTS symptoms is by preventing excessive wrist flexion during sleep, which is often a contributing factor to nerve compression. This intervention aims to maintain the wrist in a neutral or slightly extended position, thus reducing the pressure on the median nerve and allowing for improved blood flow and reduced irritation. Studies have shown that splinting can lead to improved sleep quality by minimizing discomfort and reducing nocturnal symptoms of CTS. However, the effectiveness of nocturnal splinting can be influenced by several factors, including the severity of the condition, patient adherence to treatment, and the specific design of the splint [5].

Results

The outcomes of studies evaluating nocturnal splinting for CTS have generally indicated positive results in terms of symptom relief and functional improvement. Research suggests that splinting is most effective in the early stages of CTS or when symptoms are mild to moderate. For example, a study conducted by O'Connor et al. found that patients using a neutral wrist splint for four weeks experienced a significant reduction in nighttime symptoms, such as tingling and numbness, compared to a control group that received no treatment. Other studies have reported similar findings, showing improvements in both subjective symptoms and objective measures such as grip strength and function in daily activities [6].

Additionally, nocturnal splinting has been shown to reduce the need for surgical intervention in some patients. A study by Burke et al. demonstrated that patients who adhered to a nocturnal splinting regimen for six months were less likely to require surgical treatment compared to those who did not use splints. This suggests that, for many individuals, splinting may be a sufficient treatment to manage symptoms and avoid surgery, particularly when the condition is diagnosed early. However, the results of nocturnal splinting are not universally positive. Some studies have indicated that the treatment may not provide significant benefits for all patients, especially those with severe CTS or those who have already experienced nerve damage. Furthermore, non-compliance with splinting instructions has been identified as a key factor limiting the effectiveness of the treatment, with some patients failing to wear the splint consistently due to discomfort or inconvenience [7, 8].

Discussion

The evidence suggests that nocturnal splinting is a safe and effective treatment for alleviating the symptoms of CTS, particularly in its early stages. It is a non-invasive and cost-effective alternative to more aggressive interventions such as corticosteroid injections or surgery. However, the effectiveness of splinting depends on several factors, including the severity of the condition, patient compliance, and the type of splint used. For patients with mild to moderate CTS, nocturnal splinting can significantly reduce symptoms, improve sleep quality, and enhance overall hand function [9].

One of the challenges in the application of nocturnal splinting is patient adherence to the treatment regimen. Discomfort from wearing the splint, particularly during sleep, can lead to non-compliance, which in turn reduces the effectiveness of the treatment. Custom-made splints may offer better comfort and fit, improving patient satisfaction and adherence. In contrast, prefabricated splints may be less comfortable but are more widely available and cost-effective. Another factor influencing the success of nocturnal splinting is the timing of treatment. Early intervention is critical in preventing the progression of CTS and potentially avoiding more invasive treatments. In contrast, for patients with advanced nerve damage or severe CTS, splinting may not provide significant relief, and surgical options may be necessary [10].

Conclusion

Nocturnal splinting is a widely used and effective conservative treatment for Carpal Tunnel Syndrome, particularly in patients with mild to moderate symptoms. The evidence supports its use in reducing nocturnal discomfort, improving sleep quality, and enhancing hand function. However, the success of this intervention depends on factors such as the severity of the condition, patient compliance, and the choice of splint design. Although nocturnal splinting may not be a definitive solution for all patients, it serves as an important first-line treatment that can help avoid the need for more invasive procedures in many cases. Further research is needed to explore the long-term benefits of splinting and to determine the optimal duration and design of splints for different patient populations.

1. Busch A, Jäger M, Mayer C, Sowislok A (2021) Functionalization of Synthetic Bone Substitutes. Int J Mol Sci 22: 4412

Indexed at, Google Scholar, Crossref

2. Jayash S, Al-Namnam NM, Shaghayegh G (2020) Osteoprotegerin (OPG) pathways in bone diseases and its application in therapeutic perspectives. Biointerface Res Appl Chem 10: 5193-5200.

Google Scholar, Crossref

3. Altieri B, Di Dato C, Martini C, Sciammarella C, Di Sarno A (2019) Bone Metastases in Neuroendocrine Neoplasms: From Pathogenesis to Clinical Management. Cancers 11: 1332.

Indexed at, Google Scholar, Crossref

4. Menéndez S, Gallego B, Murillo D, Rodríguez A, Rodríguez R, et al. (2021) Cancer Stem Cells as a Source of Drug Resistance in Bone Sarcomas. J Clin Med 10: 2621.

Indexed at, Google Scholar, Crossref

5. Rajani R, Gibbs CP (2012) Treatment of Bone Tumors. Surg Pathol Clin 5: 301-318.

Indexed at, Google Scholar, Crossref

6. Thanindratarn P, Dean DC, Nelson SD, Hornicek FJ, Duan Z, et al. (2019) Advances in immune checkpoint inhibitors for bone sarcoma therapy. J Bone Oncol 15: 100221.

Indexed at, Google Scholar, Crossref

7. Ferracini R, Martínez-Herreros I, Russo A, Casalini T, Rossi F, et al. (2018) Scaffolds as Structural Tools for Bone-Targeted Drug Delivery. Pharmaceutics 10: 122.

Indexed at, Google Scholar, Crossref

8. Cortini M, Baldini N, Avnet S (2019) New Advances in the Study of Bone Tumors: A Lesson from the 3D Environment. Front Physiol 10: 814.

Indexed at, Google Scholar, Crossref

9. Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66: 7-30.

Indexed at, Google Scholar, Crossref

10. Rosati LM, Herman JM (2017) Role of Stereotactic Body Radiotherapy in the Treatment of Elderly and Poor Performance Status Patients with Pancreatic Cancer. J Oncol Pract 13: 157-166.

Indexed at, Google Scholar, Crossref